This column is my opinion and expresses my views. Those views can change at a moments notice when the market changes. I am not right all the time and I do not expect to be. I disclose all my positions clearly listed on the page, and I do not trade my account on the stocks spoken of in this column unless fully disclosed. If that does not work for you stop reading and close the page. Do not bother me or harass me.
Otherwise, enjoy the column!
Subscribe to the Monster Stock Market Commentary to get the Weekly Monster Market Commentary and join the 3,180 subscribers getting it for FREE!
The Monster Week Ahead: Watching – The VIX, Nvidia, Micron, Tesla & Biotech
We could see a much more relaxed market than the one we saw last week. With Tax Reform now through the Senate, the odds seem fairly good that reconciliation can produce a tax bill to be signed by the President by year-end. That should give stocks the confidence it needs to avoid any sharp declines. Stock like Nvidia, Micron, Tesla, and the biotech sector could be in focus.
[vc_row css_animation=”” row_type=”row” use_row_as_full_screen_section=”no” type=”full_width” angled_section=”no” text_align=”left” background_image_as_pattern=”without_pattern”][vc_column][vc_tweetmeme type=”follow” follow_user=”michaelmottcm” show_followers_count=”true” large_button=”true”][/vc_column][/vc_row] Join our 3,180 Daily Subscribers And Get This Commentary In Your E-Mail! Subscribe
[widget id=”wordads_sidebar_widget-18″]
In terms of the political headline risk, that seem to always exist. But the original headlines that brought stocks lower on Friday seemed to have changed Friday night with a correction issued. The political websites can address the matter; I have to make mention of it because the S&P 500 did fall by nearly 1.7 percent from to peak to trough at one point. But stocks should feel calmer regarding this matter as well.
The Russell 2000 ETF ($IWM) was actually down by nearly 3 percent at the trough. Was the news a big deal? Yes.
[widget id=”wordads_sidebar_widget-18″]
Sign-up for our premium content on Seeking Alpha Market Place – “Reading The Markets” and a get Two Week Free Trial Period
Subscribe to the MCM Stock Market Commentary to get it weekly and join the 3,180 subscribers getting it for FREE!
Premium Content Is Great For College Students, Non-Professional, and Professional Investors. It is designed to focus on what institutional investors are watching, based on Mike’s 20 plus years of professional analytic, trading, and portfolio management career.
Premium Content: Benefits include the ability to reach out to Mike with questions through a chat room, direct message, or comments.
We will respond to questions in short order and will respond to questions with full-post or video segment, just not one or two-word answers.
Just $40 per Month
Why Tesla Could Double, And Nvidia Could Get Cut In Half
Why The S&P500 Could Melt-Up Into Year End
[widget id=”wordads_sidebar_widget-18″]
Postive Signs
There was a positive that came out of Friday’s disaster, that we learned the market has a substantial underlying bid it, one that merely likes to buy the dips. There will be a day when buy the dip becomes, sell it more aggressively. It will come.
VIX
Additionally, the VIX index shows just how concerned the market was by the end of the day on Friday, which was no concern. Because by the close, the VIX was back to where to it started the day near 11.40, despite rising to nearly 14.25 intraday.
Chip Stocks
The chipmakers were decimated during the week, with the PHLX Semiconductor ETF ($SOXX) down by nearly 6 percent, and stocks like Micron ($MU) down 15.5 percent, Lam Research ($LRCX) down almost 13.5 percent, and Nvidia ($NVDA) down by nearly 8.9 percent.
SOXX Price data by YCharts
How this group trades to start this week should be of particular interest. The group began getting some upward momentum towards the end of the day Friday, and it will be essential to see the sector continue that positive energy higher.
The best way to know if a bottom had been reached in this group would be a lower open, retesting the lows from Friday, and than a surge higher into the end of the day Monday. It would serve as confirmation of the lows reached on Friday, and that a bottom was put in place.
[widget id=”wordads_sidebar_widget-18″]
Micron
For Micron it would mean retesting the lows around $40.50 and a rally taking shares above $42.
Nvidia
For Nvidia, it means retesting a price below $194, and close above and close above $201.
Closing above $202 is very critical for Nvidia because shares of Nvidia have found themselves back in the rising wedge pattern it had been for most of 2017. As the 5-minute chart shows above, the stock was unable to break out and rise above $202, and the upper resistance trend line of the wedge. This week for Nvidia is beyond crucial.
Flip-Flop
It is a flip-flop from last week, because last week, we noted how stocks like Visa ($V) and Nvidia, were likely to lead the market higher heading into year-end. But like most investors and traders, the action and event of trading starting on Wednesday through the close on Friday blindsided me as well as many others. Which tell us that charts are great in the absence of news flow, but new News also trumps charts, and when the market has to reset, it will reset. So I reset, like or leave it.
[widget id=”wordads_sidebar_widget-18″]
Tesla
Tesla shares held up very well last week despite the volatility all over the marketplace. In fact, just look at the chart below and how the stock just stopped going down between $303 and $308. That level has been stable for Tesla since the quarterly results in mid-November.
If the stock can continue to hold this level and the broader market can regain its footing, I think Tesla could be set for a year-end rally. But I what do I know, I am likely the most bullish person on Tesla for 2018 on Wall Street, even MarketWatch noted my bullish stance, in their call of the day.
[widget id=”wordads_sidebar_widget-18″]
Biotech
If you want to know where Biotech is heading this week, watch Biogen and Celgene. Biogen shares broke-out last week and retested that breakout at the end of the week. The stock could be looking to fill the gap, next week.
While Celgene also retested its breakout.
A good week for Biotech could mean a good week for stocks and the market.
Good Luck!
Free Articles Written By Mike:
Stock Prices Plunge On Emotion, Not Reality
Nvidia, Micron, and Lam May Not Have Bottomed Yet
Why Gilead’s Highly Touted Stock Has No Upside
Why Under Armour Could Fall 65%
How Tax Cuts Could Boost Home Depot’s Stock
Nvidia Could Fall 60% After Bubble Bursts
Why Intel and Broadcom Are Still Cheap
Apple Will Rise 17% by June, Options Trades Indicate
Why Roku’s Rocketing Stock May Flame Out
Verizon’s Stock May Rise More Than 15% in 2018
Biotechs Celgene, Biogen May Rally Through Yearend
AMD May Have Bottomed, Stock Set to Rise
Macy’s, JC Penney Face More Declines, Options Trades Suggest
Why Tesla’s Plunging Stock Price Conceals A Bright Future
Why Disney and Comcast Should Fear Netflix
We offer a lot of great commentaries all week talking about the major and relevant market events. Be sure to subscribe to get all our free commentaries sent directly to your inbox or follow us on Twitter.
Join our 3,180 Daily Subscribers And Get This Commentary In Your E-Mail! Subscribe
-OR-
[vc_row css_animation=”” row_type=”row” use_row_as_full_screen_section=”no” type=”full_width” angled_section=”no” text_align=”left” background_image_as_pattern=”without_pattern”][vc_column][vc_tweetmeme type=”follow” follow_user=”michaelmottcm” show_followers_count=”true” large_button=”true”][/vc_column][/vc_row]
Michael Kramer and the Clients of Mott Capital own shares of Tesla, Celgene
Mott Capital Management, LLC is a registered investment adviser. Information presented is for educational purposes only and does not intend to make an offer or solicitation for the sale or purchase of any specific securities, investments, or investment strategies. Investments involve risk and unless otherwise stated, are not guaranteed. Be sure to first consult with a qualified financial adviser and/or tax professional before implementing any strategy discussed herein. Upon request, the advisor will provide a list of all recommendations made during the past twelve months. Past performance is not indicative of future.
© 2017 Mott Capital Management, LLC. Use, publication or reproduction in any media prohibited without the permission of the copyright holder.
Tags: #sp500 #vix #chipmakers #micron #nvidia #tesla #celgene #biogen #biotech #news #youtube #stocks #week #ahead